Target intelligence / Profile preview

RNA, 7SL, cytoplasmic 706, pseudogene (RN7SL706P)

Target: RN7SL706P
Molecular classification: Other (Pseudogene; noncoding RNA pseudogene)

Overview

RNA, 7SL, cytoplasmic 706, pseudogene (RN7SL706P) is a noncoding RNA pseudogene in the human genome derived from a reverse-transcribed fragment of the 7SL RNA, which is essential for the function of the signal recognition particle (SRP)[1][4][6]. Unlike functional 7SL RNA genes, RN7SL706P is not expressed as a functional RNA and has no known role in protein translocation, cellular signaling, or disease processes. Hundreds of related 7SL RNA pseudogenes exist in the human genome but the vast majority are considered inactive, truncated copies with high sequence diversity and no detectable biological activity[4][6]. RN7SL706P is not considered a druggable target, receptor, enzyme, or marker of disease and does not participate in canonical signaling, cellular machinery, or therapeutic pathways. It is primarily of interest for genetic mapping and as a representative of pseudogene formation phenomena in human DNA[4][6].

Other names: RN7SL706PRNA, 7SL, cytoplasmic 706, pseudogene

Mechanism of action

None (No mechanisms of action relevant for drugs or therapeutic modalities.)

Biological functions

None (Pseudogenes do not encode functional RNA/protein; only functional 7SL RNA participates in SRP-mediated protein translocation. Pseudogenes are generally nonfunctional remnants and do not have established biological roles.)

Disease associations

None (No known pathophysiological or disease roles for this pseudogene; not implicated in cancer, inflammation, or other human diseases. Functional SRP RNA and associated genes are unrelated to this locus.)

Safety considerations

None (No known safety concerns. Pseudogenes are generally ignored in clinical or pharmacological contexts.)

Interacting drugs

None (No drugs interact with this pseudogene. There are no pharmacological agents targeting pseudogenes of 7SL RNA.)

Biomarkers

None (Not used as a biomarker for patient selection, diagnosis, or monitoring.)

Beyond the preview

Go deeper on RNA, 7SL, cytoplasmic 706, pseudogene (RN7SL706P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 7SL, cytoplasmic 706, pseudogene (RN7SL706P).

Explore the full profile